GPX4 Downregulation Induces Platelet Ferroptosis in Systemic Lupus Erythematosus

Background: Ferroptosis is a recently discovered type of regulated necrosis and glutathione peroxidase 4 (GPX4) has been recognized as a key enzyme that protects against ferroptosis. However, the role of platelet GPX4 in systemic lupus erythematosus (SLE) has not been explored. In this study, GPX4 l...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhirui Zhou, Fangyuan Yang, Ying Huang, Jian Zhuang, Yuxuan Yuan, Jinli Wei, Yi He
Format: Article
Language:English
Published: World Scientific Publishing 2024-01-01
Series:Journal of Clinical Rheumatology and Immunology
Online Access:https://www.worldscientific.com/doi/10.1142/S2661341724740328
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846169772405817344
author Zhirui Zhou
Fangyuan Yang
Ying Huang
Jian Zhuang
Yuxuan Yuan
Jinli Wei
Yi He
author_facet Zhirui Zhou
Fangyuan Yang
Ying Huang
Jian Zhuang
Yuxuan Yuan
Jinli Wei
Yi He
author_sort Zhirui Zhou
collection DOAJ
description Background: Ferroptosis is a recently discovered type of regulated necrosis and glutathione peroxidase 4 (GPX4) has been recognized as a key enzyme that protects against ferroptosis. However, the role of platelet GPX4 in systemic lupus erythematosus (SLE) has not been explored. In this study, GPX4 levels in platelets were measured and the correlation with clinical features were analyzed. Methods: Platelet GPX4 protein expression was detected by Western blot and immunofluorescence in 37 SLE patients and 23 healthy controls. Clinical data were recorded at time points of blood sampling. Platelet activation was analyzed by flow cytometry, LDH release by LDH release assay and plasma oxidized DNA levels by a general 8-OHdG ELISA kit. Results: Patients with SLE had significantly decreased expression of platelet GPX4 and increased percentage of platelet activation as compared with healthy controls. Furthermore, levels of platelet GPX4 were negatively correlated with SLEDAI-2K score, 24-hour urine protein and oxidized DNA. Low GPX4 expression were associated with skin and joint involvements of SLE patients. Interestingly, deferoxamine (DFO), a ferroptosis inhibitor, could protect SLE platelets from death. Conclusions: These findings confirmed that downregulated GPX4 protein in platelets of SLE patients negatively correlated with plasma oxidized DNA, SLE disease activity and 24-hour urine protein, suggesting the potential role of platelet ferroptosis in oxidized DNA release and the pathogenesis of SLE.
format Article
id doaj-art-03a88fbdc825401d9a6fd08d6df57645
institution Kabale University
issn 2661-3417
2661-3425
language English
publishDate 2024-01-01
publisher World Scientific Publishing
record_format Article
series Journal of Clinical Rheumatology and Immunology
spelling doaj-art-03a88fbdc825401d9a6fd08d6df576452024-11-12T08:27:23ZengWorld Scientific PublishingJournal of Clinical Rheumatology and Immunology2661-34172661-34252024-01-0124supp01424210.1142/S2661341724740328GPX4 Downregulation Induces Platelet Ferroptosis in Systemic Lupus ErythematosusZhirui Zhou0Fangyuan Yang1Ying Huang2Jian Zhuang3Yuxuan Yuan4Jinli Wei5Yi He6The Third Affiliated Hospital of Southern Medical University, Guangzhou, ChinaThe Third Affiliated Hospital of Southern Medical University, Guangzhou, ChinaThe Third Affiliated Hospital of Southern Medical University, Guangzhou, ChinaThe Third Affiliated Hospital of Southern Medical University, Guangzhou, ChinaThe Third Affiliated Hospital of Southern Medical University, Guangzhou, ChinaThe Third Affiliated Hospital of Southern Medical University, Guangzhou, ChinaThe Third Affiliated Hospital of Southern Medical University, Guangzhou, ChinaBackground: Ferroptosis is a recently discovered type of regulated necrosis and glutathione peroxidase 4 (GPX4) has been recognized as a key enzyme that protects against ferroptosis. However, the role of platelet GPX4 in systemic lupus erythematosus (SLE) has not been explored. In this study, GPX4 levels in platelets were measured and the correlation with clinical features were analyzed. Methods: Platelet GPX4 protein expression was detected by Western blot and immunofluorescence in 37 SLE patients and 23 healthy controls. Clinical data were recorded at time points of blood sampling. Platelet activation was analyzed by flow cytometry, LDH release by LDH release assay and plasma oxidized DNA levels by a general 8-OHdG ELISA kit. Results: Patients with SLE had significantly decreased expression of platelet GPX4 and increased percentage of platelet activation as compared with healthy controls. Furthermore, levels of platelet GPX4 were negatively correlated with SLEDAI-2K score, 24-hour urine protein and oxidized DNA. Low GPX4 expression were associated with skin and joint involvements of SLE patients. Interestingly, deferoxamine (DFO), a ferroptosis inhibitor, could protect SLE platelets from death. Conclusions: These findings confirmed that downregulated GPX4 protein in platelets of SLE patients negatively correlated with plasma oxidized DNA, SLE disease activity and 24-hour urine protein, suggesting the potential role of platelet ferroptosis in oxidized DNA release and the pathogenesis of SLE.https://www.worldscientific.com/doi/10.1142/S2661341724740328
spellingShingle Zhirui Zhou
Fangyuan Yang
Ying Huang
Jian Zhuang
Yuxuan Yuan
Jinli Wei
Yi He
GPX4 Downregulation Induces Platelet Ferroptosis in Systemic Lupus Erythematosus
Journal of Clinical Rheumatology and Immunology
title GPX4 Downregulation Induces Platelet Ferroptosis in Systemic Lupus Erythematosus
title_full GPX4 Downregulation Induces Platelet Ferroptosis in Systemic Lupus Erythematosus
title_fullStr GPX4 Downregulation Induces Platelet Ferroptosis in Systemic Lupus Erythematosus
title_full_unstemmed GPX4 Downregulation Induces Platelet Ferroptosis in Systemic Lupus Erythematosus
title_short GPX4 Downregulation Induces Platelet Ferroptosis in Systemic Lupus Erythematosus
title_sort gpx4 downregulation induces platelet ferroptosis in systemic lupus erythematosus
url https://www.worldscientific.com/doi/10.1142/S2661341724740328
work_keys_str_mv AT zhiruizhou gpx4downregulationinducesplateletferroptosisinsystemiclupuserythematosus
AT fangyuanyang gpx4downregulationinducesplateletferroptosisinsystemiclupuserythematosus
AT yinghuang gpx4downregulationinducesplateletferroptosisinsystemiclupuserythematosus
AT jianzhuang gpx4downregulationinducesplateletferroptosisinsystemiclupuserythematosus
AT yuxuanyuan gpx4downregulationinducesplateletferroptosisinsystemiclupuserythematosus
AT jinliwei gpx4downregulationinducesplateletferroptosisinsystemiclupuserythematosus
AT yihe gpx4downregulationinducesplateletferroptosisinsystemiclupuserythematosus